Drug intelligence / Profile preview

Climavita forte

Development stage
Unknown
Lead developer
Permamed
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Climavita forte is a Swissmedic-approved herbal medicinal product developed and marketed by Permamed for the relief of menopausal symptoms, including hot flashes, sweating, sleep disturbances, nervousness, and mood swings. The active ingredient is a dry extract of the Cimicifuga racemosa rhizome (black cohosh), with each film-coated tablet containing 13 mg of the extract. Climavita forte is characterized by its non-estrogenic, organ-selective mechanism of action, functioning as a selective estrogen receptor modulator (SERM) without exerting direct estrogenic effects on the uterus or breast tissue. Additionally, it modulates central nervous system pathways, acting as an agonist at the mu-opioid receptor, 5-HT7, 5-HT1A, and 5-HT1D serotonin receptors, and the dopamine D2 receptor, which collectively contribute to temperature regulation and emotional stability during menopause.

Brand names
ClimavitaClimavita forteClimavita neo
Other names
Cimicifuga racemosa rhizome dry extractblack cohosh extract
02

Targets

HTR7 (5-hydroxytryptamine receptor 7)HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))GABAA (Gamma-aminobutyric acid receptor)MOR (Mu opioid receptor)DRD2 (Dopamine D2 Receptor)HTR1D (5-hydroxytryptamine receptor 1D)ESR2 (ERβ)ESR1 (ERα)

Beyond the preview

Go deeper on Climavita forte.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Climavita forte.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call